
Constellation Pharmaceuticals, Inc. CNST
Country |
|
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
47.5 M |
Market Cap[1] |
$ 1.63 B |
EBITDA (LTM) |
$ -14 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Scholar Rock Holding Corporation
SRRK
|
$ 47.99 | 6.46 % | $ 5.5 B | Nasdaq Global Select Market | ||
|
Lipocine
LPCN
|
$ 1.54 | -3.75 % | $ 8.39 M | Nasdaq Global Select Market | ||
|
Seres Therapeutics
MCRB
|
$ 1.45 | 2.48 % | $ 12.8 M | Nasdaq Global Select Market | ||
|
Madrigal Pharmaceuticals
MDGL
|
$ 398.15 | -5.65 % | $ 8.93 B | Nasdaq Global Select Market,SPB | ||
|
CEL-SCI Corporation
CVM
|
$ 1.38 | -25.41 % | $ 11.1 M | NYSE American,SPB | ||
|
Inventiva S.A.
IVA
|
$ 3.4 | 5.43 % | $ 203 M | Nasdaq Global Market | ||
|
MeiraGTx Holdings plc
MGTX
|
$ 8.3 | -1.89 % | $ 668 M | Nasdaq Global Select Market | ||
|
Trevi Therapeutics
TRVI
|
$ 13.55 | 0.26 % | $ 1.83 B | Nasdaq Global Market | ||
|
Eton Pharmaceuticals
ETON
|
$ 62.05 | -2.51 % | $ 1.67 B | Nasdaq Global Market | ||
|
IDEAYA Biosciences
IDYA
|
$ 26.13 | -4.64 % | $ 2.31 B | Nasdaq Global Select Market | ||
|
Protalix BioTherapeutics
PLX
|
$ 2.96 | 1.9 % | $ 232 M | NYSE American | ||
|
Lantern Pharma
LTRN
|
$ 0.33 | -10.93 % | $ 3.6 M | Nasdaq Global Select Market | ||
|
Foghorn Therapeutics
FHTX
|
$ 1.8 | -1.91 % | $ 113 M | Nasdaq Global Market | ||
|
Ocugen
OCGN
|
$ 0.73 | -2.88 % | $ 228 M | Nasdaq Capital Market | ||
|
Oncolytics Biotech
ONCY
|
$ 0.44 | 15.71 % | $ 42.2 M | Nasdaq Global Select Market | ||
|
Minerva Neurosciences
NERV
|
$ 2.18 | 0.93 % | $ 18.5 M | Nasdaq Global Market | ||
|
Kamada Ltd.
KMDA
|
$ 8.07 | -1.04 % | $ 465 M | Nasdaq Global Select Market | ||
|
Neurocrine Biosciences
NBIX
|
$ 162.75 | -1.91 % | $ 16.2 B | Nasdaq Global Select Market,SPB | ||
|
Nanobiotix S.A.
NBTX
|
$ 26.8 | -2.37 % | $ 1.28 T | Nasdaq Global Select Market | ||
|
Mereo BioPharma Group plc
MREO
|
$ 0.29 | 5.5 % | $ 231 M | Nasdaq Global Select Market | ||
|
Maravai LifeSciences Holdings
MRVI
|
$ 7.38 | 0.27 % | $ 1.07 B | Nasdaq Global Select Market | ||
|
Lexicon Pharmaceuticals
LXRX
|
$ 1.73 | -2.81 % | $ 628 M | Nasdaq Global Select Market | ||
|
Moleculin Biotech
MBRX
|
$ 6.86 | 0.44 % | $ 8.13 M | Nasdaq Global Select Market | ||
|
Arcus Biosciences
RCUS
|
$ 15.76 | -3.84 % | $ 1.69 B | NYSE,SPB | ||
|
Nurix Therapeutics
NRIX
|
$ 14.11 | -0.95 % | $ 1.22 B | Nasdaq Global Select Market,SPB | ||
|
Nkarta
NKTX
|
$ 1.2 | -4.4 % | $ 88.8 M | Nasdaq Global Select Market | ||
|
MacroGenics
MGNX
|
$ 1.98 | -3.66 % | $ 125 M | Nasdaq Global Select Market | ||
|
Protagonist Therapeutics
PTGX
|
$ 127.33 | 1.65 % | $ 8.09 B | Nasdaq Global Select Market | ||
|
Novo Nordisk A/S
NVO
|
$ 39.46 | -3.05 % | $ 175 B | NYSE | ||
|
Marker Therapeutics
MRKR
|
$ 0.83 | -0.23 % | $ 12.7 M | Nasdaq Global Market | ||
|
Replimune Group
REPL
|
$ 19.81 | 0.61 % | $ 1.84 B | Nasdaq Global Select Market | ||
|
NextCure
NXTC
|
$ 6.87 | 2.54 % | $ 36.5 M | Nasdaq Global Select Market | ||
|
Rocket Pharmaceuticals
RCKT
|
$ 2.13 | 1.18 % | $ 237 M | Nasdaq Global Select Market | ||
|
PMV Pharmaceuticals
PMVP
|
$ 1.23 | 0.41 % | $ 64.6 M | Nasdaq Global Select Market | ||
|
Olema Pharmaceuticals
OLMA
|
$ 7.17 | -0.76 % | $ 624 M | Nasdaq Global Select Market | ||
|
Kymera Therapeutics
KYMR
|
$ 121.2 | -0.27 % | $ 10.2 B | Nasdaq Global Market | ||
|
Oragenics
OGEN
|
$ 0.19 | -7.43 % | $ 410 K | NYSE American | ||
|
Ovid Therapeutics
OVID
|
$ 2.26 | 1.58 % | $ 294 M | Nasdaq Global Select Market | ||
|
Passage Bio
PASG
|
$ 4.18 | -0.95 % | $ 13.4 M | Nasdaq Global Select Market | ||
|
Vaxcyte
PCVX
|
$ 58.53 | -1.47 % | $ 7.97 B | Nasdaq Global Select Market | ||
|
Relay Therapeutics
RLAY
|
$ 16.52 | 0.33 % | $ 2.83 B | Nasdaq Global Market | ||
|
Precigen
PGEN
|
$ 4.26 | -0.7 % | $ 1.33 B | Nasdaq Global Select Market | ||
|
Avidity Biosciences
RNA
|
$ 6.65 | 2.62 % | $ 916 M | Nasdaq Global Select Market | ||
|
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.72 | 0.56 % | $ 4.31 M | Nasdaq Capital Market | ||
|
Praxis Precision Medicines
PRAX
|
$ 306.58 | 0.5 % | $ 6.9 B | Nasdaq Global Select Market,SPB | ||
|
Prelude Therapeutics Incorporated
PRLD
|
$ 3.31 | -0.3 % | $ 255 M | Nasdaq Global Select Market | ||
|
ProQR Therapeutics N.V.
PRQR
|
$ 1.09 | -5.22 % | $ 115 M | Nasdaq Global Market | ||
|
Ocular Therapeutix
OCUL
|
$ 6.04 | 0.25 % | $ 1.13 B | Nasdaq Global Select Market | ||
|
Sana Biotechnology
SANA
|
$ 1.86 | -1.33 % | $ 471 M | Nasdaq Global Select Market | ||
|
Outlook Therapeutics
OTLK
|
$ 0.4 | 11.81 % | $ 13.9 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.